Field trials in USA in 2014, 2015.
GRAS status for our first colicin products in:
GRAS status for our thaumatin sweetener in:
GRAS status for Clostridium bacteriophage endolysins in:
Bacteriocin preparations specific to Salmonella in:
- GMP certification of the facility in Halle, Germany (divested with ICON)
- successful Phase I trials in USA with NHL cancer vaccine
- Phase I-II with ZMapp anti-Ebola therapy (based on our technology)
Clear regulatory path for products based on our proprietory manufacturing process.